Clinical trial

Multiple Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes

NCT01290575

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-02-01

PhasePHASE1

Study timeline

Study start (unknown)2011-02-01Date precision: month

Registry last updated2012-03-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

PlaceboDRUG

BMS-820132DRUG

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Mapped research locations

MiamiFlorida, United States2 San AntonioTexas, United States1 PhoenixArizona, United States1 Little RockArkansas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01290575 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.